Intracellular iron levels were visualized using a KEYENCE BZ-X800
Key Takeaways Tirzepatide is an FDA-approved medication for type 2 diabetes and weight loss, acting as a dual agonist of GLP-1 and GIP receptors, which helps regulate blood sugar, suppress appetite, and slow gastric emptying
BPC-157 is not a therapeutic good and has not been evaluated or approved by the Therapeutic Goods Administration (TGA) or any other regulatory body
Alternate sides each week, left abdomen, then right thigh, then left thigh, then right abdomen, creating a four-week cycle that gives each general area a full month between injections
Research highlights that GLP-1 agonists slow gastric emptying, helping people consume fewer calories without feeling deprived